Congestive Heart Failure/Heart Transplant

  • Giuseppe Zuccalà
  • Giuseppe Colloca
  • Matteo Tosato


The term “cardiogenic dementia” was coined in 1977, in an editorial that dealt with the effects of bradycardia on cerebral electrical activity and cognition among older subjects (Editorial, 1977). The author suggested that older subjects might be particularly vulnerable to reduced cerebral perfusion due to several causes, including bradycardia. Subsequently, a study documented multiple cognitive deficits, including memory impairment, in 70% of patients undergoing cardiac rehabilitation (Barclay, Weiss, Mattis, Bond, & Blass, 1988). The authors proposed the term “circulatory dementia” to describe this form of cognitive impairment.

In the late 1990s, the issue of “cardiogenic” or “circulatory” dementia has been revisited by repeated reports on the effect of pace-maker implantation and cardiac transplantation on cognitive function (Koide, Kobayashi, Kitani, Tsunematsu, & Nakazawa, 1994; Bornstein, Starling, Myerowitz, & Haas, 1995; Grimm et al., 1996). In these studies,...


Heart Failure Cognitive Impairment Cerebral Blood Flow Mild Cognitive Impairment Cognitive Dysfunction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Adamson, P. B., Smith, A. L., Abraham, W. T., Kleckner, K. J., Stadler, R. W., Shih, A. et al. (2004). Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation, 110:2389–2394.PubMedCrossRefGoogle Scholar
  2. Almeida, OP, and Flicker, L. (2001). The mind of a failing heart: A systematic review of the association between congestive heart failure and cognitive functioning. Internal Medicine Journal, 31:290–295.PubMedCrossRefGoogle Scholar
  3. Arnold, J. M., Liu, P., Demers, C., Dorian, P., Giannetti, N., Haddad, H., et al. (2006). Canadian cardiovascular society consensus conference recommendations on heart failure 2006: diagnosis and management. Canadian Journal of Cardiology, 22(1):23–45.PubMedCrossRefGoogle Scholar
  4. Barclay, L. L., Weiss, E. M., Mattis, S., Bond, O., and Blass, J. P. (1988). Unrecognized cognitive impairment in cardiac rehabilitation patients. Journal of the American Geriatrics Society, 36:22–28.PubMedGoogle Scholar
  5. Barker, W. H., Mullooly, J. P., and Getchell, W. (2006). Changing incidence and survival for heart failure in a well-defined older population, 1970–1974 and 1990–1994. Circulation, 113:799–805.PubMedCrossRefGoogle Scholar
  6. Bennett, S. J. and Sauve, M. J. (2003). Cognitive deficits in patients with heart failure: a review of the literature. Journal of Cardiovascular Nursing, 18(3):219–242.Google Scholar
  7. Bornstein, R. A., Starling, R. C., Myerowitz, P., and Haas, G. J. (1995). Neuropsychological function in patients with end-stage heart failure before and after cardiac transplantation. Acta Neurologica Scandinavica, 91:260–265.PubMedCrossRefGoogle Scholar
  8. Braunstein, J. B., Anderson, G. F., Gerstenblith, G. Weller,W., Niefeld, M., Herbert, R., et al. (2003). Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. Journal of the American College of Cardiology, 42:1226–1233.PubMedCrossRefGoogle Scholar
  9. Breteler, M. M., Van Swieten, J. C., Bots, M. L., Grobbee, D. E., Claus, J. J., van den Hout, J. H. et al. (1994). Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study. Neurology, 44:1246–1252.PubMedGoogle Scholar
  10. Buffon, F., Porcher, R., Hernandez, K., Kurtz, A., Pointeau, S., Vahedi, K., et al. (2006). Cognitive profile in CADASIL. Journal of Neurology, Neurosurgery, and Psychiatry, 77:175–180.PubMedCrossRefGoogle Scholar
  11. Cacciatore, F., Abete, P., Ferrara, N., Calabrese, C., Napoli, C., Maggi, S., et al. (1998). Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. Journal of the American Geriatrics Society, 46(11):1343–1348.Google Scholar
  12. Carbonin, P., Zuccala, G.,Marzetti, E., and Monaco, M. (2003). Coronary risk factors in the elderly: Their interactions and treatment. Current Pharmaceutical Design, 9(29): 2465–2478.Google Scholar
  13. Chaytor, N., Schmitter-Edgecombe, M., and Burr, R. (2006). Improving the ecological validity of executive functioning assessment. Archives of Clinical Neuropsychology, 21:217–227.PubMedCrossRefGoogle Scholar
  14. Cummings, J. L. (1994). Vascular subcortical dementias: clinical aspects. Dementia;5:177–80.Google Scholar
  15. Dai, W. J., Funk, A., Herdegen, T., Unger, T. and Culman, J. (1999). Blockade of central angiotensin AT1 receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 30:2391–2299.PubMedCrossRefGoogle Scholar
  16. Deshields, T. L., McDonough, E. M., Mannen, R. K., and Miller, L. W. (1996). Psychological and cognitive status before and after heart transplantation. General Hospital Psychiatry, 18(6 Suppl):62S–69S.Google Scholar
  17. Deswal, A., Petersen, N. J., Feldman, A. M., Young, J. B., White, B. G., and Mann, D. L. (2001). Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the VESnarinone Trial (VEST). Circulation, 103:2055–2059.PubMedGoogle Scholar
  18. Editorial. (1977). Cardiogenic dementia. Lancet, 1:27–28.Google Scholar
  19. Fabris, B., Chen, B. Z., Pupic, V., Perich, R., and Johnston, C. I. (1990). Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue. Journal of Cardiovascular Pharmacology, 15(S2):S6–S13.CrossRefGoogle Scholar
  20. Fogari, R., Mugellini, A., Zoppi, A., Derosa, G., Pasotti, C., Fogari, E., et al. (2003). Influence of losartan and atenolol on memory function in very elderly hypertensive patients. Journal of Human Hypertension 17:781–785.PubMedCrossRefGoogle Scholar
  21. Fournier, A., Messerli, F. H., Achard, J. M., and Fernandez, L. (2004). Cerebroprotection mediated by angiotensin II – a hypothesis supported by recent randomized clinical trials. Journal of the American College of Cardiology, 43:1343–1347.PubMedCrossRefGoogle Scholar
  22. Georgiadis, D., Sievert, M., Cencetti, S., Uhlmann, F., Krivokuca, M., Zierz, S., et al. (2000). Cerebrovascular reactivity is impaired in patients with cardiac failure. European Heart Journal, 21:407–413.PubMedCrossRefGoogle Scholar
  23. Glynn, R. J., Beckett, L. A., Herbert, L. E. , Morris, M. C., Scherr, P. A., and Evans, D. A. (1999). Current and remote blood pressure and cognitive decline. JAMA 281:438–445.PubMedCrossRefGoogle Scholar
  24. Grimm, M., Yeganehfar, W., Laufer, G., Madl, C., Kramer, L. Eisenhuber, E., et al. (1996). Cyclosporine may affect improvement of cognitive brain function after successful cardiac transplantation. Circulation, 94:1339–1345.PubMedGoogle Scholar
  25. Gruhn, N., Larsen, F., and Boesgaard, S. (2001). Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke, 32:2530–2533.PubMedCrossRefGoogle Scholar
  26. Haldeman, G. A., Croft, J. B., Giles, W. H., and Rashidee, A. (1999). Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. American Heart Journal, 137:352–360.PubMedCrossRefGoogle Scholar
  27. Hu, K., Bahner, U., Gaudron, P., Palkovits, M., Ring, M., Fehle, A., et al. (2001). Chronic effects of ACE-inhibiiton (quinapril) and angiotensin-II type-1 receptor blockade (losartan) on atrial natriuretic peptide in brain nuclei of rats with experimental myocardial infarction. Basic Research in Cardiology 96:258–266.PubMedCrossRefGoogle Scholar
  28. Ishani, A., Weinhandl, E., Zhao, Z., Gilbertson, D. T., Collins, A. J., Yusuf, S., et al. (2005). Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. Journal of the American College of Cardiology, 45:391–399.PubMedCrossRefGoogle Scholar
  29. Kamishirado, H., Inoue, T., Fujito, T., Kase, M., Shimizu, M., Sakai, Y. et al., (1997). Effect of enalapril maleate on cerebral blood flow in patients with chronic heart failure. Angiology, 48:707–713.PubMedCrossRefGoogle Scholar
  30. Katz, S. D., Marantz, P. R., Biasucci, L., Jondeau, G., Lee, K., Brennan, C., et al. (1993). Low incidence of stroke in ambulatory patients with heart failure: a prospective study. American Heart Journal, 126:141–146.PubMedCrossRefGoogle Scholar
  31. Kilander, L., Nyman, H., Boberg, M., Hansson, L., and Lithell, H. (1998). Hypertension is related to cognitive impairment. Hypertension 31:780–786.PubMedGoogle Scholar
  32. Koide, H., Kobayashi, S., Kitani, M., Tsunematsu, T., and Nakazawa, Y. (1994). Improvement of cerebral blood flow and cognitive function following pacemaker implantation in patients with bradycardia. Gerontology 40:79–85.CrossRefGoogle Scholar
  33. Konstam, M. A. (2000). Progress in heart failure management? Lessons from the real world. Circulation 102:1076–1078.PubMedGoogle Scholar
  34. Konstam, M. A., Lindenfeld, J., Pina, I. L., Packer, M., Lazar, R. M., and Warner Stevenson, L. (2004). Key issues in trial design for ventricular assist devices: a position statement of the Heart Failure Society of America. Journal of Cardiac Failure 10:91–100.PubMedCrossRefGoogle Scholar
  35. Konstam, V., Salem, D., Pouleur, H., Kostis, J., Gorkin, L., Shumaker, S., et al. (1996). Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. The American Journal of Cardiology 78:890–895.PubMedCrossRefGoogle Scholar
  36. Lang, C. C., and Mancini, D. M. (2006). Noncardiac comorbidities in heart failure. Heart, 93: 665–71.Google Scholar
  37. Launer, L. J., Masaki, R., Petrovich, H., Foley, D., and Havlik, R.J. (1995). Association between midlife blood pressure levels and late-life cognitive function. JAMA 274:1846–1851.PubMedCrossRefGoogle Scholar
  38. Lee, C. W., Lee, J., Lim, T. H., Yang, H. S., Hong, M.-K., Song, J.-K. et al. (2001). Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure. Circulation 103:2784–2787.PubMedGoogle Scholar
  39. Li, J., Culman, J., Hörtnagl, H., Zhao, Y., Gerova, N., Timm, M., et al. (2005). Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB Journal 19:617–619.PubMedGoogle Scholar
  40. Lipschitz, D. (2003). Medical and functional consequences of anemia in the elderly. Journal of the American Geriatrics Society 51:S10–S13.PubMedCrossRefGoogle Scholar
  41. Lipton, S. A. (2004). Erythropoietin for neurologic protection and diabetic neuropathy. The New England Journal of Medicine, 350:2516–2517.PubMedCrossRefGoogle Scholar
  42. Lou, M., Blume, A., Zhao, Y., Gohlke, P., Deuschl, G., Herdegen, T., et al. (2004). Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurological deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat. Journal of Cerebral Blood Flow and Metabolism, 24:536–547.PubMedGoogle Scholar
  43. Mathias, C. J. (2000). Cerebral hypoperfusion and impaired cerebral function in cardiac failure. European Heart Journal, 21:346.PubMedCrossRefGoogle Scholar
  44. McCullough, P. A., Philbin, E. F., Spertus, J. A., Kaatz, S., Sandberg, K. R., and Weaver, W. D. (2002). Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. Journal of the American College of Cardiology. 39:60–69.PubMedCrossRefGoogle Scholar
  45. Melamed, E., Lavy, S., Bentin, S., Cooper, G., and Rinot, Y. (1980). Reduction in regional cerebral blood flow during normal aging in man. Stroke 11:31–35.PubMedCrossRefGoogle Scholar
  46. Metry, G., Wickstrom, B., Valind, S., Sandhagen, B., Linde, T., Beshara, S., et al. (1999). Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients. Journal of the American Society of Nephrology, 10:854–863.PubMedGoogle Scholar
  47. Mosterd, A., Hoes, A. W., de Bruyne, M. C., Deckers, J. W., Linker, D. T., Hofman, A., et al. (1999). Prevalence of heart failure and left ventricular dysfunction in the general population: the Rotterdam Study. European Heart Journal 20:447–455.PubMedCrossRefGoogle Scholar
  48. Mungas, D., Jagust, W. J., Reed, B. R., Jagust, W. J., DeCarli, C., Beckett, L. et al. (2001). MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease. Neurology 57:2229–2235.PubMedGoogle Scholar
  49. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study. (2001). Pathological correlates of late-onset dementia in a multicentre, community-based populationin England and Wales. Lancet 357:169–175.CrossRefGoogle Scholar
  50. Nissenson AR. (1999). Epoetin and cognitive function. American Journal of Kidney Diseases. 20:21–24.Google Scholar
  51. Nissenson, A. R., Goodnough, L. T., Dubois, R. W. (2003). Anemia—not just an innocent bystander? Archives of Internal Medicine. 163:1400–1404.PubMedCrossRefGoogle Scholar
  52. Normand, S. L., Rector, T. S., Neaton, D. J. Pina, I. L., Lazar, R. M., Proestel, S. E., et al. (2005). Clinical considerations in the study of health status in device trials for heart failure. Journal of Cardiac Failure, 11:396–403.PubMedCrossRefGoogle Scholar
  53. Pan HL. (2004). Brain angiotensin II and synaptic transmission. Neuroscientist 10:422–431.PubMedCrossRefGoogle Scholar
  54. Petrucci, R. J., Truesdell, K. C., Carter, A., Goldstein, N. E., Russell, M. M., Dilkes, D., et al. (2006). Cognitive dysfunction in advanced heart failure and prospective cardiac assist device patients. Annals of Thoracic Surgery, 81(5):1738–1744.Google Scholar
  55. Price, C. G., Jefferson, A. L., Merino, J. G., Heilman, K. M. and Libon, D. J. (2005). Subcortical vascular dementia. Integrating neuropsychological and neuroradiologic data. Neurology 65:376–382.PubMedCrossRefGoogle Scholar
  56. Pullicino, P. M., Hart, J. (2001). Cognitive impairment in congestive heart failure? Embolism vs hypoperfusion. Neurology 57:1945–1946.PubMedGoogle Scholar
  57. Putzke, J. D., Williams, M. A., Millsaps, C. L., Azrin, R. L., LaMarche, J. A., Bourge, R. C., et al. (1997). Heart transplant candidates: A neuropsychological descriptive database. Journal of Clinical Psychology in Medical Settings, 4(3):343–355.Google Scholar
  58. Putzke, J. D., Williams, M. A., Daniel, F., Foley, B. A., Kirklin, J. K., and Boll, T. J. (2000). Neuropsychological functioning among heart transplant candidates: A case control study. Journal of Clinical and Experimental Neuropsychology, 22(1):95–103.Google Scholar
  59. Rich, M. W. (2001). Heart failure in the 21st century: a cardiogeriatric syndrome. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 56:M88–M96.PubMedCrossRefGoogle Scholar
  60. Rich, M. W., and Nease, R. F. (1999). Cost-effectiveness analysis in clinical practice. The case of heart failure. Archives of Internal Medicine 159: 1690–1700.PubMedCrossRefGoogle Scholar
  61. Roman, G. C. (2004). Brain hypoperfusion: a critical factor in vascular dementia. Neurology Research. 26:454–58.CrossRefGoogle Scholar
  62. Royall, D. R., Cordes, J. A., and Polk, M. (1998). CLOX: an executive clock drawing task. Journal of Neurology, Neurosurgery, and Psychiatry 64:588–594.PubMedCrossRefGoogle Scholar
  63. Royall, D. R., Palmer, R., Chiodo, L. K., and Polk, M. J. (2005). Executive control mediates memory's association with change in instrumental activities of daily living: the Freedom House Study. Journal of the American Geriatrics Society 53:11–17.PubMedCrossRefGoogle Scholar
  64. Schall, R. R.. Petrucci, R. J., Brozena, S. C., Cavarocchi, N. C., and Jessup, M. (1989). Cognitive function in patients with symptomatic dilated cardiomyopathy before and after cardiac transplantation. Journal of the American College of Cardiology, 14(7):1666–1672.Google Scholar
  65. Silverberg, D. S., Wexler, D., Sheps, D., Blum, M., Keren, G., Baruch, R., et al. (2001). The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. Journal of the American College of Cardiology. 37:1775–1780.CrossRefGoogle Scholar
  66. Skoog I, Lernfelt B, Landahal S Palmertz, B., Andreasson, L.-A., Nilsson, L., et al. (1996). A 15 year longitudinal study on blood pressure and dementia. Lancet 347:1141–1145.PubMedCrossRefGoogle Scholar
  67. Slooter, A. J., Tang, M. X., van Duijn, C. M., Stern, Y., Ott, A., Bell, K., et al. (1997). Apolipoprotein E epsilon 4 and the risk of dementia with stroke. A population-based investigation. JAMA 277:818–821.CrossRefGoogle Scholar
  68. Sparks, D. L., Sabbagh, M. N., Connor, D. J., Lopez, J., Launer, L. J., Browne, P., et al. (2005). Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Archives of Neurology 62:753–757.PubMedCrossRefGoogle Scholar
  69. Tang, W. H. W., and Francis, G. S. (2005). The year in heart failure. Journal of the American College of Cardiology 46:2125–2133.CrossRefGoogle Scholar
  70. Tarvonen, S., Roytta, M., Raiha, I., Kurki, T., Rajala, T., and Sourander, L. (1996). Clinical features of leukoaraiosis. Journal of Neurology, Neurosurgery, and Psychiatry, 60:431–436.CrossRefGoogle Scholar
  71. Trojano, L., Antonelli Incalzi, R., Acanfora, D., Picone, C., Mecocci, P., Rengo, F., et al. (2003). Cognitive impairment: a key feature of congestive heart failure in the elderly. Journal of Neurology, 250(12):1456–1463.Google Scholar
  72. Tzourio, C., Anderson, C., Chapman, N., Woodward, M., Neal, B., MacMahon S., et al. (2003). Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Archives of Internal Medicine 163:1069–1075.PubMedCrossRefGoogle Scholar
  73. van den Heuvel, D. M., ten Dam, V. H., de Craen, A. J., Admiraal-Behloul, F., Olofsen, H., Bollen, E. L., et al. (2006). Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. Journal of Neurology, Neurosurgery, and Psychiatry 77:149–153.PubMedCrossRefGoogle Scholar
  74. Verghese, J., Lipton, R. B., Hall, C. B., Kuslansky, G., and Katz, M. J. (2003). Low blood pressure and the risk of dementia in very old individuals. Neurology 61:1667–1672.PubMedGoogle Scholar
  75. Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., and Yaffe, K. (2005). Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64:277–281.PubMedCrossRefGoogle Scholar
  76. Wolinsky, F. D., Smith, D. M., Stump, T. E., Overhage, J. M., and Lubitz, R. M. (1997). The sequelae of hospitalization for congestive heart failure among older adults. Journal of the American Geriatrics Society. 45:558–563.PubMedGoogle Scholar
  77. Yaffe, K., Kanaya, A., Lindquist, K., Simonsick, E. M., Harris, T., Shorr, R. I., et al. (2004). The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292:2237–2242.PubMedCrossRefGoogle Scholar
  78. Zamrini, E., McGwin, G., and Roseman, J. M. (2004). Association between statin use and Alzheimer's disease. Neuroepidemiology 23:94–98.PubMedCrossRefGoogle Scholar
  79. Zimpfer, D., Wieselthaler, G., Czerny, M., Fakin, R., Haider, D., Zrunek, P., et al. (2006). Neurocognitive function in patients with ventricular assist devices. A comparison of pulsatile and continuous blood flow devices. ASAIO Journal 52:24–27.PubMedCrossRefGoogle Scholar
  80. Zuccalá, G., Cattel, C., Gravina-Manes, E., Di Niro, M. G., Cocchi, A., and Bernabei, R., (1997). Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. Journal of Neurology, Neurosurgery, and Psychiatry, 63:509–512.PubMedCrossRefGoogle Scholar
  81. Zuccalà, G., Onder, G., Pedone, C., Carosella, L., Pahor, M., Bernabei, R., et al. (2001a). Hypotension and cognitive impairment: selective association in patients with heart failure. Neurology 59:1986–1992.Google Scholar
  82. Zuccalá, G., Onder, G., Pedone, C., Cocchi, A., Cattel, C., Carbonin, P. U. et al. (2001b). Cognitive dysfunction as a major determinant of disability in patients with heart failure: results from a multicentre survey. Journal of Neurology, Neurosurgery, and Psychiatry 70:109–112.Google Scholar
  83. Zuccalá, G., Pedone, C., Cesari, M., Onder, G., Pahor, M., Marzetti, E., et al. (2003). The effects of cognitive impairment on mortality among hospitalized patients with heart failure. The American Journal of Medicine 115:97–103.PubMedCrossRefGoogle Scholar
  84. Zuccalà, G., Marzetti, E., Cesari, M., Lo Monaco, MR., Antonica, L., Cocchi, A.,, et al. (2005a). Correlates of cognitive impairment among patients with heart failure: Results of a multicenter survey. The American Journal of Medicine 118:496–502.Google Scholar
  85. Zuccalà, G., Onder, G., Marzetti, E., Monaco, M. R., Cesari, M., Cocchi, A., et al. (2005b). Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure. European Heart Journal 26: 226–233.Google Scholar
  86. Zulli, R., Nicosia, F., Borroni, B., Agostil, C.,. Prometti, P., Donati, P., et al. (2005). QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment. Journal of the American Geriatrics Society, 53:2135–2139.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Giuseppe Zuccalà
    • 1
  • Giuseppe Colloca
    • 1
  • Matteo Tosato
    • 1
  1. 1.Department of GerontologyCatholic University of the Sacred HeartL.go F. VitoItaly

Personalised recommendations